[TM] YoY Annualized Quarter Result on 31-Dec-2010 [#4]

Announcement Date
25-Feb-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Dec-2010 [#4]
Profit Trend
QoQ- 12.29%
YoY- 87.62%
View:
Show?
Annualized Quarter Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 10,628,679 9,993,537 9,150,655 8,791,002 8,607,991 8,674,917 8,295,953 4.21%
PBT 1,046,045 1,069,582 1,001,151 1,360,192 921,588 353,803 918,670 2.18%
Tax 1,771 236,334 235,926 -115,182 -248,310 547,375 1,712,927 -68.16%
NP 1,047,816 1,305,916 1,237,077 1,245,010 673,278 901,178 2,631,597 -14.21%
-
NP to SH 1,012,211 1,263,731 1,190,969 1,206,448 643,026 791,865 2,547,692 -14.24%
-
Tax Rate -0.17% -22.10% -23.57% 8.47% 26.94% -154.71% -186.46% -
Total Cost 9,580,863 8,687,621 7,913,578 7,545,992 7,934,713 7,773,739 5,664,356 9.14%
-
Net Worth 7,137,715 6,899,684 6,966,989 7,689,237 6,928,868 10,209,205 19,713,109 -15.56%
Dividend
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Div 933,853 787,594 700,990 928,858 808,174 903,758 3,869,478 -21.07%
Div Payout % 92.26% 62.32% 58.86% 76.99% 125.68% 114.13% 151.88% -
Equity
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Net Worth 7,137,715 6,899,684 6,966,989 7,689,237 6,928,868 10,209,205 19,713,109 -15.56%
NOSH 3,577,981 3,579,974 3,576,483 3,558,843 3,513,803 3,442,891 3,424,317 0.73%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin 9.86% 13.07% 13.52% 14.16% 7.82% 10.39% 31.72% -
ROE 14.18% 18.32% 17.09% 15.69% 9.28% 7.76% 12.92% -
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 297.06 279.15 255.86 247.02 244.98 251.97 242.27 3.45%
EPS 28.29 35.30 33.30 33.90 18.30 23.00 74.40 -14.87%
DPS 26.10 22.00 19.60 26.10 23.00 26.25 113.00 -21.65%
NAPS 1.9949 1.9273 1.948 2.1606 1.9719 2.9653 5.7568 -16.17%
Adjusted Per Share Value based on latest NOSH - 3,577,071
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 276.95 260.40 238.44 229.07 224.30 226.04 216.17 4.21%
EPS 26.38 32.93 31.03 31.44 16.76 20.63 66.39 -14.24%
DPS 24.33 20.52 18.27 24.20 21.06 23.55 100.83 -21.08%
NAPS 1.8599 1.7979 1.8154 2.0036 1.8055 2.6602 5.1367 -15.56%
Price Multiplier on Financial Quarter End Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 -
Price 5.55 6.04 4.96 3.51 3.06 1.54 5.60 -
P/RPS 1.87 2.16 1.94 1.42 1.25 0.61 2.31 -3.45%
P/EPS 19.62 17.11 14.89 10.35 16.72 6.70 7.53 17.28%
EY 5.10 5.84 6.71 9.66 5.98 14.94 13.29 -14.74%
DY 4.70 3.64 3.95 7.44 7.52 17.05 20.18 -21.54%
P/NAPS 2.78 3.13 2.55 1.62 1.55 0.52 0.97 19.16%
Price Multiplier on Announcement Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 27/02/14 27/02/13 24/02/12 25/02/11 22/02/10 24/02/09 26/02/08 -
Price 5.59 5.32 5.08 3.85 3.35 1.67 5.70 -
P/RPS 1.88 1.91 1.99 1.56 1.37 0.66 2.35 -3.64%
P/EPS 19.76 15.07 15.26 11.36 18.31 7.26 7.66 17.09%
EY 5.06 6.64 6.56 8.81 5.46 13.77 13.05 -14.59%
DY 4.67 4.14 3.86 6.78 6.87 15.72 19.82 -21.39%
P/NAPS 2.80 2.76 2.61 1.78 1.70 0.56 0.99 18.90%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment